Table 2.
Seroprevalence: comparison of assays between baseline and follow-up.
| Baseline | Follow-up | p value | |
|---|---|---|---|
| Diasorin LIAISON | 88/109 (81%) | 91/109 (83%) | n.s. |
| Euroimmun ELISA | 90/109 (83%) | 85/109 (78%) | n.s. |
| Abbott architect | 64/109 (59%) | 26/109 (24%) | 0.0001 |
| Seropositive in one assay | 92/109 (84%) | 101/109 (93%) | n.s. |
| Seropositive in two assays | 88/109 (81%) | 77/109 (71%) | n.s. |
| Seropositive in three assays | 62/109 (57%) | 24/109 22%) | 0.0001 |
n.s. not significant.